Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
IKang Healthcare Group (ADR) (KANG US)
Watchlist
62
Analysis
Health Care
•
China
iKang Healthcare Group, Inc is a corporate preventative healthcare provider. The Company provides medical examination, screening and other services. iKang focuses in mainland China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Chindata Group
•
05 Dec 2023 15:38
Dissenters Mobilise As Chindata (CD US)'s Shareholders Approve Bain's Offer
This is done. Trading at a 2% gross spread to terms, or ~14% annualised assuming late-Jan completion. Not bad. Not great. It was certainly more...
David Blennerhassett
Follow
716 Views
Share
bullish
•
VNET Group
•
17 Nov 2023 12:10
Hina/IBC's Non-Binding Proposal For VNET
Shandong Hi-Speed Holdings (412 HK) is investing US$299mn (@US$0.497/share) in VNET to take a 42.12% stake on a fully diluted basis, and 35.7% of...
David Blennerhassett
Follow
1.1k Views
Share
bearish
•
VNET Group
•
14 Sep 2022 11:39
VNET: Management's Low-Balled Non-Binding Proposal
Trading at a ~45% gross spread to terms is illustrative of the proposal's non-binding nature. It's an opportunistic approach. Only for the brave at...
David Blennerhassett
Follow
461 Views
Share
bullish
•
Glory Star New Media Group Holdings
•
13 Jul 2022 12:36
Offensively Cheap Homecoming For Glory Star New Media
Trading at a 17.4%/40.9% gross/annualised spread, assuming late December completion. That's attractive. Get involved if you've read this far.
David Blennerhassett
Follow
712 Views
Share
bullish
•
51 Job Inc Adr
•
22 Jun 2021 15:58
51job’s Privatisation: Firm Offer Is Still The Wrong Price
I'd buy here. Given recent Cayman petitions, I would expect this pushback on pricing to continue here, which may avail smaller investors the...
David Blennerhassett
Follow
581 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x